New combo therapy aims to wipe out early anal cancer without surgery
Disease control
Recruiting now
This study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (carboplatin and paclitaxel) and radiation can completely eliminate early-stage anal cancer. About 23 adults with stage I to IIIA anal cancer will receive weekly chemo-immunotherapy plus…
Phase: PHASE2 • Sponsor: Dustin Deming • Aim: Disease control
Last updated May 12, 2026 13:42 UTC